KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Intangibles (2016 - 2024)

Edwards Lifesciences (EW) has 11 years of Change in Intangibles data on record, last reported at $4.6 million in Q4 2024.

  • For Q4 2024, Change in Intangibles changed N/A year-over-year to $4.6 million; the TTM value through Sep 2025 reached $4.6 million, down 81.89%, while the annual FY2024 figure was $30.0 million, 125.56% up from the prior year.
  • Change in Intangibles reached $4.6 million in Q4 2024 per EW's latest filing, down from $5.4 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $20.0 million in Q1 2024 and bottomed at $200000.0 in Q2 2023.
  • Average Change in Intangibles over 3 years is $7.3 million, with a median of $5.0 million recorded in 2024.
  • The widest YoY moves for Change in Intangibles: up 52.67% in 2024, down 52.67% in 2024.
  • A 3-year view of Change in Intangibles shows it stood at $300000.0 in 2020, then plummeted by 33.33% to $200000.0 in 2023, then surged by 2200.0% to $4.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Change in Intangibles were $4.6 million in Q4 2024, $5.4 million in Q3 2024, and $20.0 million in Q1 2024.